Details for: NIMENRIX
Company: PFIZER CANADA ULC
DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
---|---|---|---|---|---|
02402904 | NIMENRIX | MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y; TETANUS TOXOID | 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 44 MCG / 0.5 ML | POWDER FOR SOLUTION | INTRAMUSCULAR |
02402904 | NIMENRIX | MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP A; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP C; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP W-135; MENINGOCOCCAL POLYSACCHARIDE ANTIGEN GROUP Y; TETANUS TOXOID | 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 5 MCG / 0.5 ML; 44 MCG / 0.5 ML | KIT | INTRAMUSCULAR |
Summary Reports
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.